Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reed Miller

Manager, Commercial/R&D

Washington, DC

Reed focuses on new technology development, including clinical trials and investment start-up companies. He has been covering medical technology since joining The Gray Sheet in 2000, and also covered cardiovascular technology for theheart.org and drug industry compliance issues for HCPro. Reed has a BA in religion from the College of William & Mary and an MA in Philosophy of Religion from Boston University. He lives and works in his hometown of State College, Pennsylvania.

Latest From Reed Miller

TCT 2022: Trial Of Boston Scientific’s TAVR Embolic Protector Misses Endpoint, But May Offer 'Hope'

New trial data shows Boston Scientific’s Sentinel cerebral embolic protection device may reduce the risk of disabling stroke, but it does not appear to reduce the overall risk of stroke.

Clinical Trials Cardiovascular

TCT 2022: Edwards Ready To Take On Abbott In Mitral Repair Market With ‘Premium’ Device

Edwards Lifesciences is ramping up US commercialization of its Pascal Precision mitral valve transcatheter edge-to-edge repair device, the first US competitor for Abbott’s MitraClip. The FDA approved Pascal Precision earlier than the company expected, based on results of the CLASP IID trial.

Approvals Business Strategies

TCT 2022: Edwards' Pascal Matches Abbott's MitraClip In CLASP IID

Results of the CLASP IID trial showed Edwards’ Pascal mitral valve repair system was non-inferior for safety and effectiveness compared to Abbott’s MitraClip device.

Clinical Trials Cardiology

Insights From the Wells Fargo Health Care Conference

Medtech executives at the the Wells Fargo Healthcare Conference talked about the challenges facing them now, including hospital staffing shortages, supply chain constraints, and inflation. Here are some of the highlights from their comments

Business Strategies Commercial

Minute Insight: Butterfly Deploys POC Ultrasound In Kenya To Support New Mothers

The company received a $5m grant from the Bill & Melinda Gates Foundation to improve access to medical imaging across Sub-Saharan Africa.

Minute Insights Diagnostic Imaging

Report: Baxter Considers Dropping Renal Care Businesses

Bloomberg reported that Baxter is exploring options to divest its renal care services and hemodialysis businesses to focus more resources on higher-growth businesses and pay down the debt it took on to acquire Hillrom last year.

Restructuring Renal
See All
UsernamePublicRestriction

Register